Related Experiment Video
Updated: Nov 22, 2025

Olfactory Assays for Mouse Models of Neurodegenerative Disease
Published on: August 25, 2014
Olfactory impairment in Wilson's disease.
Lei Chen1, Xin Wang1, Richard L Doty2
1Department of Neurology, Tianjin Huan Hu Hospital, Tianjin Key Laboratory of Cerebrovascular and Neurodegenerative Diseases, Tianjin, China.
Patients with Wilson's disease (WD) show impaired smell identification. Specific odors can help screen for WD, potentially aiding in early diagnosis and prediction of the neurodegenerative disorder.
Area of Science:
- Neurology
- Neuroscience
- Ophthalmology
Background:
- Olfactory dysfunction is an early indicator of neurodegenerative diseases.
- Olfactory function in Wilson's disease (WD) is not well understood.
- WD is a genetic disorder causing copper accumulation.
Purpose of the Study:
- To assess olfactory identification in WD patients.
- To identify specific odors for WD screening.
Main Methods:
- Olfactory identification was measured using the University of Pennsylvania Smell Identification Test (UPSIT) in 25 WD patients and 25 controls.
- Neurological status was assessed using the Global Assessment Scale for WD (GAS).
- Logistic regression and ROC curve analysis were used to identify screening odors.
Main Results:
- WD patients had significantly worse smell identification than controls (p=0.033).
- Smell identification scores negatively correlated with neurological severity in WD patients (r=-0.571, p=0.003).
- A combination of seven odors achieved an AUC of 0.926, and three odors (onion, licorice, jasmine) achieved an AUC of 0.852 for discriminating WD patients.
Conclusions:
- WD patients exhibit stable, selective olfactory impairments.
- These olfactory deficits may serve as a diagnostic and predictive tool for WD.
- Specific odor combinations show potential for developing a WD screening test.
Related Concept Videos
Olfactory Receptors: Location and Structure
Olfaction
The olfactory receptors are embedded in the cilia of the...
Physiology of Smell and Olfactory Pathway
The olfactory...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Prosopagnosia
Taste Buds and Receptors

